Control of Beta Cell Function by Co-activators
Control of Beta Cell Function by Co-activators
批准号:
6935179
负责人:
FREDRIC E. WONDISFORD
金额:
$49.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2008-08-31
关键词:
AP1 proteinDNA binding proteinbiological signal transductioncell differentiationcell proliferationgene expressiongene targetinggenetic regulatory elementgenetic transcriptiongenetically modified animalshormone regulation /control mechanisminsulinlaboratory mousepancreatic islet functionphosphorylationprotein protein interactionprotein structure function
中文摘要
描述(由申请人提供):
这项拨款建议是为了回应RFA DK 02014,题为:“β细胞生物学综合计划。“我的实验室研究核激素受体的转录调节机制,最近对基于胰岛素信号传导的核靶点研究的β细胞中共激活因子的特定作用产生了兴趣。该提议以几种方式响应RFA:1)我是糖尿病领域的新研究者,对胰岛素对β细胞的转录调节感兴趣; 2)提出转基因和敲除(KO)动物模型来研究β细胞蛋白在其生理环境中的作用; 3)提出研究两种共激活剂在β细胞中的作用,CBP和p300;和4)将探索β细胞特异性蛋白PDX-1在胰岛素刺激的基因表达和R细胞增殖中的作用。胰腺中胰岛素基因转录的调节涉及特定的正和负顺式作用元件。位于5'侧翼区。胰岛素基因表达的一个主要调节因子是同源框蛋白PDX-1(也称为IPF-1、STF-1和IDX-1)。这种蛋白质在小鼠中首次表达于e8.5,在胰腺发育和β细胞功能中具有主要作用,如分别在全身性和条件性PDX-1 KO小鼠中所证明的。胰岛素转录和β细胞发育的第二个主要调节因子是碱性螺旋-环-螺旋(bHLH)蛋白NeuroDI 43 -2,其与广泛表达的E2 A蛋白形成DNA结合复合物。PDX-1和NeuroDI/β 3-2均显示与高度相关的CBP和p300共激活蛋白相互作用。这些共激活因子已被证明在哺乳动物发育的许多方面至关重要,包括它们对有丝分裂原反应基因的功能;基于体外研究,它们也被认为是胰岛素基因转录所必需的。然而,尚不清楚它们在β细胞生长和功能中起什么作用,以及它们的功能在β细胞中是组成性的还是受调节的。提出了三个目标:1)确定通过AP-1复合物的胰岛素信号传导在胰腺β细胞增殖反应中的作用; 2)确定在胰腺β细胞中重要的CBP和p300中的组成型和激素调节的相互作用结构域;和3)确定CBP和p300在携带CBP或p300的细胞特异性敲除的小鼠中的成人β细胞中的作用。本提案的总体目标是确定CBP和p300在调节胰腺β细胞生长和功能中的作用机制
英文摘要
DESCRIPTION (provided by applicant):
This grant proposal is in response to RFA DK 02014 entitled: "Comprehensive Programs in Beta Cell Biology." My laboratory studies mechanisms of transcriptional regulation by nuclear hormone receptors and has recently become interested in the specific role of co-activators in the beta cell based on the study of nuclear targets for insulin signaling. This proposal is responsive to the RFA in several ways: 1) I am a new investigator to the diabetes field interested in transcriptional regulation of the beta-cell by insulin; 2) transgenic and knockout (KO) animal models are proposed to study beta-cell proteins in their physiological context; 3) a study of the role of two co-activators in then-cell, CBP and p300, are proposed; and 4) the role of a beta-cell-specific protein, PDX-1, in insulin-stimulated gene expression and R-cell proliferation will be explored. Regulation of insulin gene transcription in the pancreas involves specific positive and negative cis-acting elements. located in the 5' flanking region. One major regulator of insulin gene expression is the homeobox protein, PDX-1 (also referred to as IPF-1, STF-1, and IDX-1). This protein, first expressed at e8.5 in the mouse, has a major role in pancreatic development and (beta-cell function as demonstrated in both generalized and conditional PDX-1 KO mice; respectively. A second major regulator of both insulin transcription and (beta-cell development is the basic helix-loop-helix (bHLH) protein, NeuroDI43-2, which forms a DNA-binding complex with the ubiquitously expressed E2A proteins. Both PDX-1 and NeuroDI/(3-2 have been shown to interact with the highly related CBP and p300 co-activator proteins. These co-activators have proven to be critical in many aspects of mammalian development, including their function on mitogen-responsive genes; they have also been proposed to be essential for insulin gene transcription based on in vitro studies. It is unclear, however, what role they play in (beta-cell growth and function, and whether their function is constitutive or regulated in the (beta cell. Three Aims are proposed: 1) To-define the role of insulin signaling via the AP-1 complex in proliferative responses of the pancreatic (beta cell; 2) To define constitutive and hormonal regulated interaction domains in CBP and p300 important in the pancreatic (beta cell; and 3) To define the role of CBP and p300 in the adult (beta-cell in mice harboring a cell-specific knock out of either CBP or p300. The overall goal of this proposal will be to determine the mechanism of CBP and p300 action in regulating pancreatic beta-cell growth and function
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diabetes Research and Training Center
-
批准号:8063800
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2010
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:7908051
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2009
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:7591690
-
项目类别:
-
资助金额:$161.27万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
JHU-UMD Diabetes Research Center
-
批准号:8629726
-
项目类别:
-
资助金额:$194.28万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:9221323
-
项目类别:
-
资助金额:$115.11万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
CORE E: TRANSGENIC CORE
-
批准号:8868984
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:7768466
-
项目类别:
-
资助金额:$161.27万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
CORE E: TRANSGENIC CORE
-
批准号:9221322
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
JHU-UMD Diabetes Research Center
-
批准号:8435759
-
项目类别:
-
资助金额:$192.23万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:8040922
-
项目类别:
-
资助金额:$161.27万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:7336878
-
项目类别:
-
资助金额:$177.03万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:8217272
-
项目类别:
-
资助金额:$163.63万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8629730
-
项目类别:
-
资助金额:$123.02万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8443960
-
项目类别:
-
资助金额:$111.03万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Diabetes Research and Training Center
-
批准号:7825015
-
项目类别:
-
资助金额:$48.62万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
CORE E: TRANSGENIC CORE
-
批准号:8629729
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
CORE E: TRANSGENIC CORE
-
批准号:8443956
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2008
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Control of Beta Cell Function by Co-activators
-
批准号:6800902
-
项目类别:
-
资助金额:$9.82万
-
财政年份:2002
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Transcriptional coactivators and hepatic glucose production
-
批准号:9174174
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2002
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
Control of Beta Cell Function by Co-activators
-
批准号:6574977
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2002
-
负责人:FREDRIC E. WONDISFORD
-
依托单位:
海外基金